Ambrisentan for Early Low-Risk Pulmonary Arterial Hypertension

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Epistemonikos ID: 663599a8930d428ae8bbd510c9bba7c2596c29c1
First added on: May 24, 2025